Exact Sciences Corporation announced its third-quarter 2023 results. Here’s a summary:
- Revenue: The company reported a total revenue of $1.6 billion, which is a 22% increase compared to the third quarter of 2022.
- Net Income: Exact Sciences posted a net income of $210 million, marking a significant improvement from the previous year’s third quarter.
- Earnings Per Share (EPS): The earnings per share stood at $1.45.
- Guidance: For the full year of 2023, the company expects a revenue in the range of $6.3 billion to $6.4 billion. Additionally, they anticipate an adjusted earnings per share between $5.60 and $5.70.
- Operational Highlights: The company highlighted its commitment to advancing cancer diagnostics and shared that it has made significant progress in its product pipeline. This includes the launch of new products and enhancements to existing ones.
- CEO’s Statement: Kevin Conroy, the Chairman and CEO of Exact Sciences, expressed his pride in the team’s achievements. He emphasized the company’s dedication to delivering innovative solutions that make a difference in patients’ lives.